FPV — 2016 Investments
1 investments dated 2016 · listed companies and verified rows first · show all
Modernamodernatx.comin𝕏Aug 2016
Moderna develops mRNA-based medicines for infectious and serious diseases using its proprietary mRNA platform and design technology.
BiotechDeep TechMedical DevicesCambridge, US
Robert Langer(Director)Lorence Kim(Executive Officer)inJames R. Kasinger(Executive Officer)inStephen Hoge(Executive Officer)in
BoardStephane Bancel(Executive Officer, Director)John Mendlein(Director)
Co-investorsAglae VenturesBlackstone Life SciencesFlagship PioneeringKhosla VenturesPremji InvestRA Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.